Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00322634 · ClinicalTrials.gov registry record
Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
A clinical trial of Cancer, sponsored by New Mexico Cancer Research Alliance.
- Completed
- Registry status
- 25
- Enrollment target
- 5
- Study locations
NCT00322634: Completed study of Cancer, sponsored by New Mexico Cancer Research Alliance.
NCT00322634 is a study of Cancer that has completed, run by New Mexico Cancer Research Alliance. The registered enrollment target is 25 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00322634, a study of Cancer, has completed, sponsored by New Mexico Cancer Research Alliance.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 5
- Study locations
Study Summary
The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
Conditions Studied
Study Locations (5)
New Mexico
- Hematology Oncology Associates - Albuquerque
- Radiation Oncology Associates - Albuquerque
- University of New Mexico - Albuquerque
- New Mexico Cancer Care Associates - Santa Fe
- St. Vincent Regional Medical Center - Santa Fe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-02 |
| Est. Completion | 2011-07 |
What the finished NCT00322634 record still lists
NCT00322634 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00322634 lists 5 locations in 1 state (New Mexico).
Frequently Asked Questions
What is clinical trial NCT00322634 about?
NCT00322634 is a clinical study titled "Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors". The use of performance status and LDH in combination can predict patient survival more accurately than physician clinical impression or the patients' own feelings about their survival
What is the current status of trial NCT00322634?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2006-02. Estimated completion is 2011-07.
What conditions does trial NCT00322634 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT00322634?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00322634 being conducted?
This trial has 5 study locations across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00322634's enrollment target sits among peer trials
25 537th of 615 higher than 71 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia